Follow
Daniela Loessner
Daniela Loessner
Associate Professor in Biomedical Engineering
Verified email at monash.edu
Title
Cited by
Cited by
Year
Bioengineered 3D platform to explore cell–ECM interactions and drug resistance of epithelial ovarian cancer cells
D Loessner, KS Stok, MP Lutolf, DW Hutmacher, JA Clements, SC Rizzi
Biomaterials 31 (32), 8494-8506, 2010
7342010
Functionalization, preparation and use of cell-laden gelatin methacryloyl–based hydrogels as modular tissue culture platforms
D Loessner, C Meinert, E Kaemmerer, LC Martine, K Yue, PA Levett, ...
Nature protocols 11 (4), 727-746, 2016
7072016
Can tissue engineering concepts advance tumor biology research?
DW Hutmacher, D Loessner, S Rizzi, DL Kaplan, DJ Mooney, ...
Trends in biotechnology 28 (3), 125-133, 2010
2802010
Design and fabrication of tubular scaffolds via direct writing in a melt electrospinning mode
TD Brown, A Slotosch, L Thibaudeau, A Taubenberger, D Loessner, ...
Biointerphases 7 (1-4), 1-16, 2012
2602012
Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research
VMC Quent, D Loessner, T Friis, JC Reichert, DW Hutmacher
Journal of cellular and molecular medicine 14 (4), 1003-1013, 2010
2552010
Gelatine methacrylamide-based hydrogels: an alternative three-dimensional cancer cell culture system
E Kaemmerer, FPW Melchels, BM Holzapfel, T Meckel, DW Hutmacher, ...
Acta biomaterialia 10 (6), 2551-2562, 2014
2322014
Translating tissue engineering technology platforms into cancer research
DW Hutmacher, RE Horch, D Loessner, S Rizzi, S Sieh, JC Reichert, ...
Journal of cellular and molecular medicine 13 (8a), 1417-1427, 2009
1842009
Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells
MG Lawrence, NV Margaryan, D Loessner, A Collins, KM Kerr, M Turner, ...
The Prostate 71 (11), 1198-1209, 2011
1252011
Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone
BM Holzapfel, F Wagner, D Loessner, NP Holzapfel, L Thibaudeau, ...
Biomaterials 35 (13), 4108-4115, 2014
1212014
Kallikrein-related peptidase 7 promotes multicellular aggregation via the α5β1 integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma
Y Dong, OL Tan, D Loessner, C Stephens, C Walpole, GM Boyle, ...
Cancer research 70 (7), 2624-2633, 2010
1092010
The kallikrein-related peptidase family: Dysregulation and functions during cancer progression
T Kryza, ML Silva, D Loessner, N Heuzé-Vourc'h, JA Clements
Biochimie 122, 283-299, 2016
1012016
3D approaches to model the tumor microenvironment of pancreatic cancer
E Tomás-Bort, M Kieler, S Sharma, JB Candido, D Loessner
Theranostics 10 (11), 5074, 2020
932020
Tissue engineered humanized bone supports human hematopoiesis in vivo
BM Holzapfel, DW Hutmacher, B Nowlan, V Barbier, L Thibaudeau, ...
Biomaterials 61, 103-114, 2015
832015
Endosteal-like extracellular matrix expression on melt electrospun written scaffolds
ML Muerza-Cascante, A Shokoohmand, K Khosrotehrani, D Haylock, ...
Acta biomaterialia 52, 145-158, 2017
792017
The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior
C Lenski, RF Kooy, E Reyniers, D Loessner, RJA Wanders, ...
The American Journal of Human Genetics 80 (2), 372-377, 2007
722007
A bioengineered 3D ovarian cancer model for the assessment of peptidase–mediated enhancement of spheroid growth and intraperitoneal spread
D Loessner, SC Rizzi, KS Stok, T Fuehrmann, B Hollier, V Magdolen, ...
Biomaterials 34 (30), 7389-7400, 2013
712013
TGFBI production by macrophages contributes to an immunosuppressive microenvironment in ovarian cancer
LSM Lecker, C Berlato, E Maniati, R Delaine-Smith, OMT Pearce, O Heath, ...
Cancer Research 81 (22), 5706-5719, 2021
692021
Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells
H Shahinian, D Loessner, ML Biniossek, JN Kizhakkedathu, JA Clements, ...
Molecular oncology 8 (1), 68-82, 2014
692014
Growth of confined cancer spheroids: a combined experimental and mathematical modelling approach
D Loessner, JA Flegg, HM Byrne, JA Clements, DW Hutmacher
Integrative Biology 5 (3), 597-605, 2013
682013
Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses
D Loessner, BM Holzapfel, JA Clements
Advanced drug delivery reviews 79, 193-213, 2014
632014
The system can't perform the operation now. Try again later.
Articles 1–20